Cargando…
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. RESULTS: This commentary of highlights has resulted in 21 different topics selected by each member of the...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426445/ https://www.ncbi.nlm.nih.gov/pubmed/34495412 http://dx.doi.org/10.1186/s41181-021-00146-9 |
_version_ | 1783750042231767040 |
---|---|
author | Alves, Francisco Antunes, Inês F. Cazzola, Emiliano Cleeren, Frederik Cornelissen, Bart Denkova, Antonia Engle, Jonathan Faivre-Chauvet, Alain Gillings, Nic Hendrikx, Jeroen J. M. A. Jalilian, Amir R. van der Meulen, Nicholas P. Mikolajczak, Renata Neels, Oliver C. Pillai, Maroor R. A. Reilly, Raymond Rubow, Sietske Seimbille, Yann Spreckelmeyer, Sarah Szymanski, Wiktor Taddei, Carlotta |
author_facet | Alves, Francisco Antunes, Inês F. Cazzola, Emiliano Cleeren, Frederik Cornelissen, Bart Denkova, Antonia Engle, Jonathan Faivre-Chauvet, Alain Gillings, Nic Hendrikx, Jeroen J. M. A. Jalilian, Amir R. van der Meulen, Nicholas P. Mikolajczak, Renata Neels, Oliver C. Pillai, Maroor R. A. Reilly, Raymond Rubow, Sietske Seimbille, Yann Spreckelmeyer, Sarah Szymanski, Wiktor Taddei, Carlotta |
author_sort | Alves, Francisco |
collection | PubMed |
description | BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. RESULTS: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. CONCLUSIONS: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry. |
format | Online Article Text |
id | pubmed-8426445 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-84264452021-09-29 Highlight selection of radiochemistry and radiopharmacy developments by editorial board Alves, Francisco Antunes, Inês F. Cazzola, Emiliano Cleeren, Frederik Cornelissen, Bart Denkova, Antonia Engle, Jonathan Faivre-Chauvet, Alain Gillings, Nic Hendrikx, Jeroen J. M. A. Jalilian, Amir R. van der Meulen, Nicholas P. Mikolajczak, Renata Neels, Oliver C. Pillai, Maroor R. A. Reilly, Raymond Rubow, Sietske Seimbille, Yann Spreckelmeyer, Sarah Szymanski, Wiktor Taddei, Carlotta EJNMMI Radiopharm Chem Review BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. RESULTS: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. CONCLUSIONS: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry. Springer International Publishing 2021-09-08 /pmc/articles/PMC8426445/ /pubmed/34495412 http://dx.doi.org/10.1186/s41181-021-00146-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Alves, Francisco Antunes, Inês F. Cazzola, Emiliano Cleeren, Frederik Cornelissen, Bart Denkova, Antonia Engle, Jonathan Faivre-Chauvet, Alain Gillings, Nic Hendrikx, Jeroen J. M. A. Jalilian, Amir R. van der Meulen, Nicholas P. Mikolajczak, Renata Neels, Oliver C. Pillai, Maroor R. A. Reilly, Raymond Rubow, Sietske Seimbille, Yann Spreckelmeyer, Sarah Szymanski, Wiktor Taddei, Carlotta Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
title | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
title_full | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
title_fullStr | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
title_full_unstemmed | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
title_short | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
title_sort | highlight selection of radiochemistry and radiopharmacy developments by editorial board |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426445/ https://www.ncbi.nlm.nih.gov/pubmed/34495412 http://dx.doi.org/10.1186/s41181-021-00146-9 |
work_keys_str_mv | AT alvesfrancisco highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT antunesinesf highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT cazzolaemiliano highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT cleerenfrederik highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT cornelissenbart highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT denkovaantonia highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT englejonathan highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT faivrechauvetalain highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT gillingsnic highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT hendrikxjeroenjma highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT jalilianamirr highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT vandermeulennicholasp highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT mikolajczakrenata highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT neelsoliverc highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT pillaimaroorra highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT reillyraymond highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT rubowsietske highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT seimbilleyann highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT spreckelmeyersarah highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT szymanskiwiktor highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT taddeicarlotta highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard |